Dolby Laboratories (Dolby Laboratories) Total Liabilities : $573 Mil (As of Dec. 2023)

View and export this data going back to 2005. Start your Free Trial

What is Dolby Laboratories Total Liabilities?

Dolby Laboratories's Total Liabilities for the quarter that ended in Dec. 2023 was $573 Mil.

Dolby Laboratories's quarterly Total Liabilities declined from Jun. 2023 ($625.22 Mil) to Sep. 2023 ($607.58 Mil) and declined from Sep. 2023 ($607.58 Mil) to Dec. 2023 ($573.22 Mil).

Dolby Laboratories's annual Total Liabilities declined from Sep. 2021 ($501.46 Mil) to Sep. 2022 ($438.53 Mil) but then increased from Sep. 2022 ($438.53 Mil) to Sep. 2023 ($607.58 Mil).

Dolby Laboratories Total Liabilities Historical Data

The historical data trend for Dolby Laboratories's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dolby Laboratories Total Liabilities Chart

Dolby Laboratories Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Total Liabilities

Get a 7-Day Free Trial

508.72

478.92

501.46

438.53

607.58

Dolby Laboratories Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Total Liabilities	Get a 7-Day Free Trial															456.00	480.14	625.22	607.58	573.22

Dolby Laboratories Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Dolby Laboratories's Total Liabilities for the fiscal year that ended in Sep. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	422.226	+	(37.02	+	104.037
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	39.997	+	4.302)
	=	608

Total Liabilities	=	Total Assets (A: Sep. 2023 )	-	Total Equity (A: Sep. 2023 )
	=	2979.766	-	2372.184
	=	608

Dolby Laboratories's Total Liabilities for the quarter that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	394.096	+	(34.319	+	103.425
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	36.994	+	4.385)
	=	573

Total Liabilities	=	Total Assets (Q: Dec. 2023 )	-	Total Equity (Q: Dec. 2023 )
	=	2935.529	-	2362.31
	=	573

Dolby Laboratories Total Liabilities Related Terms

Thank you for viewing the detailed overview of Dolby Laboratories's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Dolby Laboratories (Dolby Laboratories) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Business Services » Dolby Laboratories Inc (NYSE:DLB) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

FUO:Germany FUO:Germany

Address

1275 Market Street, San Francisco, CA, USA, 94103-1410

Website

https://www.dolby.com

Dolby Laboratories Inc develops audio and surround sound for cinema, broadcast, home audio systems, in-car entertainment systems, DVD players, games, televisions, and personal computers. The company generates three fourths of its revenue from licensing its technology to consumer electronics manufacturers around the world. The rest of revenue comes from equipment sales to professional producers and audio engineering services.

Executives

Kevin J Yeaman	officer: VP, Chief Financial Officer	C/O DOLBY LABORATORIES, INC., 1275 MARKET STREET, SAN FRANCISCO CA 94103
Mark Andrew Sherman	officer: EVP, GEN. COUN. & SECRTY	DOLBY LABORATORIES, INC., 1275 MARKET STREET, SAN FRANCISCO CA 94103
John D Couling	officer: SVP, Entertainment	C/O DOLBY LABORATORIES, INC., 1275 MARKET STREET, SAN FRANCISCO CA 94103
Todd Pendleton	officer: SVP, Chief Marketing Officer	1275 MARKET STREET, SAN FRANCISCO CA 94103
Emily Rollins	director	C/O DOLBY LABORATORIES, INC., 1275 MARKET STREET, SAN FRANCISCO CA 94103
Anjali Sud	director	C/O VIMEO INC., 555 WEST 18TH STREET, NEW YORK NY 10011
Simon Segars	director	C/O DOLBY LABORATORIES, INC., 1275 MARKET STREET, SAN FRANCISCO CA 94103
Avadis Tevanian	director	DOLBY LABORATORIES INC, 1275 MARKET STREET, SAN FRANCISCO CA 94103
Peter C Gotcher	director
Ryan Nicholson	officer: VP, Corporate Controller	C/O DOLBY LABORATORIES INC., 1275 MARKET STREET, SAN FRANCISCO CA 94103
Shriram Revankar	officer: SVP, Advanced Technology Group	C/O DOLBY LABORATORIES, INC., 1275 MARKET STREET, SAN FRANCISCO CA 94103
Tony A Prophet	director	9 BERNICE STREET, SAN FRANCISCO CA 94103
Robert J Park	officer: SVP & Chief Financial Officer	C/O DOLBY LABORATORIES, INC., 1275 MARKET STREET, SAN FRANCISCO CA 94103
Steven E Forshay	officer: Sr. Vice President, Research	1275 MARKET STREET, SAN FRANCISCO CA 94103
Lewis Chew	officer: EVP, Chief Financial Officer	DOLBY LABORATORIES, INC., 1275 MARKET STREET, SAN FRANCISCO CA 94103